Design and synthesis of some new benzoylthioureido benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors

References

• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008;7(2):168–181.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases as drug targets - an overview. Curr Top Med Chem. 2007;7(9):825–833.
   PubMed Web of Science ®Google Scholar
• Abdalkareem Jasim S, Kzar HH, Haider Hamad M, Ahmad I, Al-Gazally ME, Ziyadullaev S, Sivaraman R, Abed Jawad M, Thaeer Hammid A, Oudaha KH, et al. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update. Int Immunopharmacol. 2022;110:109074.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Donald WA, Supuran CT. Human carbonic anhydrases: tissue distribution, physiological role, and druggability. In: Supran CT, Nocentini A, editors. Carbonic anhydrases. Cambridge: Academic press; 2019. p. 151–185.
   Google Scholar
• Aspatwar A, Parvathaneni NK, Barker H, Anduran E, Supuran CT, Dubois L, Lambin P, Parkkila S, Winum J-Y. Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series. J Enzyme Inhib Med Chem. 2020;35(1):109–117.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors. J Exp Pharmacol. 2020;12:603–617.
   PubMedGoogle Scholar
• Oudah KH, Najm MAA, Roomi AB, Al-Sa’idy HA, Awadallah FM. The recent progress of sulfonamide in medicinal chemistry. Syst Rev Pharm. 2020;11(12):1473–1477.
   Google Scholar
• Raya I, Chupradit S, Mustafa YF, et al. Carboxymethyl chitosan nano-fibers for controlled releasing 5-fluorouracil anticancer drug. J Nanostruct. 2022;12(1):136–143.
   Web of Science ®Google Scholar
• Cakmak EB, Zengin Kurt B, Ozturk Civelek D, Angeli A, Akdemir A, Sonmez F, Supuran CT, Kucukislamoglu M. Quinoline-sulfamoyl carbamates/sulfamide derivatives: synthesis, cytotoxicity, carbonic anhydrase activity, and molecular modelling studies. Bioorg Chem. 2021;110:104778.
   PubMed Web of Science ®Google Scholar
• Lolak N, Akocak S, Bua S, Sanku RKK, Supuran CT. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors. Bioorg Med Chem. 2019;27(8):1588–1594.
   PubMed Web of Science ®Google Scholar
• Shaldam M, Nocentini A, Elsayed ZM, Ibrahim TM, Salem R, El-Domany RA, Capasso C, Supuran CT, Eldehna WM. Development of novel quinoline-based sulfonamides as selective cancer-associated carbonic anhydrase isoform ix inhibitors. IJMS. 2021;22(20):11119.
   Google Scholar
• Awadallah FM, El-Waei TA, Hanna MM, Abbas SE, Ceruso M, Oz BE, Guler OO, Supuran CT. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives. Eur J Med Chem. 2015;96:425–435.
   PubMed Web of Science ®Google Scholar
• Awadallah FM, Bua S, Mahmoud WR, Nada HH, Nocentini A, Supuran CT. Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails. J Enzyme Inhib Med Chem. 2018;33(1):629–638.
   PubMed Web of Science ®Google Scholar
• Al-Bahadily DCH, Chaloob R, Oudah KH, Al-Salman HNK, Shari FH, Hussein HH. Fasten, simple, and specific stability of the avant-garde RP-HPLC method for estimation and validation of nystatin in pharmaceutical formulations. Int J Res Pharm Sci. 2019;10(4):3717–3727.
   Google Scholar
• Zhang Z. Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic use. WO 2017004543. Published online 2017.
   Google Scholar
• Liguori F, Carradori S, Ronca R, Rezzola S, Filiberti S, Carta F, Turati M, Supuran CT. Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells. J Enzyme Inhib Med Chem. 2022;37(1):1857–1869.
   PubMed Web of Science ®Google Scholar
• Akgul O, Singh S, Andring JT, McKenna R, Selleri S, Carta F, Angeli A, Supuran CT. Handling drug-target selectivity: a study on ureido containing carbonic anhydrase inhibitors. Eur J Med Chem. 2021;212:113035.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang W, Huang J, Zhao Z, Li H, Xu Y. Novel benzoyl thioureido benzene sulfonamides as highly potent and selective inhibitors of carbonic anhydrase IX: optimization and bioactive studies. Medchemcomm. 2018;9(12):2100–2105.
   PubMed Web of Science ®Google Scholar
• Elbadawi MM, Eldehna WM, Nocentini A, Somaa WR, Al-Rashood ST, Elkaeed EB, El Hassab MA, Abdel-Aziz HA, Supuran CT, Fares M, et al. Development of 4-((3-oxo-3-phenylpropyl)amino)benzenesulfonamide derivatives utilizing tail/dual-tail approaches as novel carbonic anhydrase inhibitors. Eur J Med Chem. 2022;238:114412.
   PubMed Web of Science ®Google Scholar
• Bonardi A, Nocentini A, Bua S, Combs J, Lomelino C, Andring J, Lucarini L, Sgambellone S, Masini E, McKenna R, et al. Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand/isoform matching and selectivity of action. J Med Chem. 2020;63(13):7422–7444.
   PubMed Web of Science ®Google Scholar
• Said MF, George RF, Petreni A, Supuran CT, Mohamed NM. Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors with antiproliferative activity. J Enzyme Inhib Med Chem. 2022;37(1):701–717.
   PubMed Web of Science ®Google Scholar
• Nada H, Elkamhawy A, Abdellattif MH, Angeli A, Lee CH, Supuran CT, Lee K. 4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies. J Enzyme Inhib Med Chem. 2022;37(1):994–1004.
   PubMed Web of Science ®Google Scholar
• Sarnella A, Ferrara Y, Auletta L, Albanese S, Cerchia L, Alterio V, De Simone G, Supuran CT, Zannetti A. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion. J Exp Clin Cancer Res. 2022;41(1):1–16.
   PubMed Web of Science ®Google Scholar
• Bonardi A, Bua S, Combs J, Lomelino C, Andring J, Osman SM, Toti A, Di Cesare Mannelli L, Gratteri P, Ghelardini C, et al. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. J Enzyme Inhib Med Chem. 2022;37(1):930–939.
   PubMed Web of Science ®Google Scholar
• Zeng F, Li S, Yang G, Luo Y, Qi T, Liang Y, Yang T, Zhang L, Wang R, Zhu L, et al. Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis. Acta Pharm Sin B. 2021;11(3):795–809.
   Web of Science ®Google Scholar
• Srivastav M, Shantakumar SM. Synthesis and anti-inflammatory activity of some novel 3-(6-Substituted-1, 3-Benzothiazole-2-Yl)-2-[{(4-Substituted Phenyl) Amino} Methyl] quinazolines-4 (3H)-ones. 2009;6(4):1055–1062.
   Google Scholar
• AydIn F, Ünver H, Aykaç D, Iskeleli NO. Spectroscopic studies and structure of 4-(3-benzoylthioureido)benzoic acid. J Chem Crystallogr. 2010;40(12):1082–1086.
   Web of Science ®Google Scholar
• Saeed A, Mumtaz A, Florke U. Synthesis, characterization and crystal structure of 1-(4-methylbenzoyl)-3-(4 aminosulfonylphenyl)thiourea. Eur J Chem. 2010;1(2):73–75.
   Google Scholar
• Oudah KH, Najm MAA, Samir N, Serya RAT, Abouzid KA. Design, synthesis and molecular docking of novel pyrazolo[1,5-a][1,3,5]triazine derivatives as CDK2 inhibitors. Bioorg Chem. 2019;92:103239.
   PubMed Web of Science ®Google Scholar
• Yazdani E, Kazemi Miraki M, Salamatmanesh A, Azarnia J, Azizi K, Ghandi L, Heydari A. A magnetically recoverable copper–salen complex as a nano-catalytic system for amine protection via acetylation using thioacetic acid. Res Chem Intermed. 2019;45(4):1775–1793.
   Web of Science ®Google Scholar
• Das VK, Devi RR, Thakur AJ. Recyclable, highly efficient and low cost nano-MgO for amide synthesis under SFRC: A convenient and greener “NOSE” approach. Appl Catal A Gen. 2013;456:118–125.
   Web of Science ®Google Scholar
• Song B, Xiao T, Qi X, Li L-N, Qin K, Nian S, Hu G-X, Yu Y, Liang G, Ye F, et al. Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors. Bioorg Med Chem Lett. 2012;22(4):1739–1742.
   PubMed Web of Science ®Google Scholar
• Gawel JM, Shouksmith AE, Raouf YS, Nawar N, Toutah K, Bukhari S, Manaswiyoungkul P, Olaoye OO, Israelian J, Radu TB, et al. PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia. Eur J Med Chem. 2020;201:112411.
   PubMed Web of Science ®Google Scholar
• Basanagouda M, Kulkarni MV, Kalkhambkar RG, Kulkarni GM. ChemInform abstract: new, efficient, selective, and one-pot method for acylation of amines. ChemInform. 2008;38(17):2929–2940.
   Google Scholar
• Das VK, Devi RR, Raul PK, Thakur AJ. Nano rod-shaped and reusable basic Al2O3 catalyst for N-formylation of amines under solvent-free conditions: A novel, practical and convenient NOSE’ approach. Green Chem. 2012;14(3):847–854.
   Web of Science ®Google Scholar
• Saeed S, Bhatti MH, Yunus U, Jones PG. Ethyl 4-(3-benzoylthioureido)benzoate. Acta Crystallogr Sect E Struct Reports Online. 2008;64(8):o1485.
   Google Scholar
• Mahdavi M, Shirazi MS, Taherkhani R, Saeedi M, Alipour E, Moghadam FH, Moradi A, Nadri H, Emami S, Firoozpour L, et al. Synthesis, biological evaluation and docking study of 3-aroyl-1-(4- sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors. Eur J Med Chem. 2014;82:308–313.
   PubMed Web of Science ®Google Scholar
• Noori SD, Kadhi MS, Najm MAA, Oudah KH, Qasim QA, Al-Salman HNK. In-vitro evaluation of anticancer activity of natural flavonoids, apigenin and hesperidin. Mater Today Proc. 2022;60:1840–1843.
   Google Scholar
• Burley SK, Bhikadiya C, Bi C, Bittrich S, Chen L, Crichlow GV, Christie CH, Dalenberg K, Di Costanzo L, Duarte JM, et al. RCSB Protein Data Bank: Powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res. 2021;49(D1):D437–D451.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The Carbon Dioxide Hydration Activity of Carbonic Anhydrase: I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem. 1971;246(8):2561–2573.
   PubMed Web of Science ®Google Scholar
• Singh P, Purnachander Yadav P, Swain B, Thacker PS, Angeli A, Supuran CT, Arifuddin M. Discovery of a novel series of indolylchalcone-benzenesulfonamide hybrids acting as selective carbonic anhydrase II inhibitors. Bioorg Chem. 2021;108(January):104647.
   PubMedGoogle Scholar
• Dar’in D, Kantin G, Kalinin S, Sharonova T, Bunev A, Ostapenko GI, Nocentini A, Sharoyko V, Supuran CT, Krasavin M, et al. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent. Eur J Med Chem. 2021;222:113589.
   PubMed Web of Science ®Google Scholar
• Yamali C, Inci Gul H, Ozli G, Angeli A, Ballar Kirmizibayrak P, Erbaykent Tepedelen B, Sakagami H, Bua S, Supuran CT. Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides. Bioorg Chem. 2021;115(July):105194.
   PubMedGoogle Scholar
• Elbadawi MM, Eldehna WM, Nocentini A, Abo-Ashour MF, Elkaeed EB, Abdelgawad MA, Alharbi KS, Abdel-Aziz HA, Supuran CT, Gratteri P, et al. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities. Eur J Med Chem. 2021;218:113360.
   PubMed Web of Science ®Google Scholar
• Daina A, Zoete V. A Boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 2016;11(11):1117–1121.
   PubMed Web of Science ®Google Scholar
• Ursu O, Oprea TI. Model-free drug-likeness from fragments. J Chem Inf Model. 2010;50(8):1387–1394.
   PubMed Web of Science ®Google Scholar
• Subik K, Lee J-F, Baxter L, Strzepek T, Costello D, Crowley P, Xing L, Hung M-C, Bonfiglio T, Hicks DG, et al. The expression patterns of ER, PR, HER2, CK5/6, EGFR, KI-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer. 2010;4(1):35–41.
   PubMedGoogle Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):1–13.
   Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1-3):3–26.
   PubMed Web of Science ®Google Scholar
• Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem. 1999;1(1):55–68.
   PubMedGoogle Scholar